| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/13/2004 | US20040091924 Method for detecting base mutation |
| 05/13/2004 | US20040091912 Diagnostic method |
| 05/13/2004 | US20040091908 Useful in drug design methods to identify agents that may interact with active sites |
| 05/13/2004 | US20040091907 GEF-H1b: biomarkers, complexes assays and therapeutic uses thereof |
| 05/13/2004 | US20040091906 Correlating biochemical component(DNA) of cell to nuclear volume using mathematical techniques; use in characterizing based on desired phenotype or differentiating among benign, malignant and metastatic states to diagnose cancer |
| 05/13/2004 | US20040091904 Methods for identifying compounds that bind to a target |
| 05/13/2004 | US20040091899 Cross-linking reagent bound by means of a coupling agent of given formula (silane compound) |
| 05/13/2004 | US20040091895 Human sprouty-4 polypeptide |
| 05/13/2004 | US20040091894 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof |
| 05/13/2004 | US20040091893 Measuring and comparing gene expression in bacterium-colonized and germ-free stomachs; DNA microarray analysis and/or polymerase chain reaction; evaluation of biochemical pathway of angiogenin-4 or colipase |
| 05/13/2004 | US20040091890 Life sciences business systems and methods |
| 05/13/2004 | US20040091889 Obtaining tissue or sample DNA or RNA from a potential tumor cell; Amplification by polymerase chain reaction; Southern hybridization or RNase A mismatch cleavage; useful in diagnosis and prognosis of cancer |
| 05/13/2004 | US20040091884 For diagnosis of/drugs for inflammatory bowel disease/asthma/ diabetes/arthritis/cirrhosis/skin disorders |
| 05/13/2004 | US20040091880 Method for direct genetic analysis of target cells by using fluorescence probes |
| 05/13/2004 | US20040091878 Zinc finger domain recognition code and uses thereof |
| 05/13/2004 | US20040091877 Bound to first phase that reflects electromagnetic waves; for DNA/RNA/peptides/peptide nucleic acids |
| 05/13/2004 | US20040091876 Method for screening ligand having biological activity |
| 05/13/2004 | US20040091874 For surface plasmon resonance measurement of polypeptide binding |
| 05/13/2004 | US20040091867 Nitrogen fixation; solid phase synthesis; temperature controlling |
| 05/13/2004 | US20040091866 Methods for identifying novel nucleic acid regulatory elements and compounds that affect the regulation |
| 05/13/2004 | US20040091864 Hybridisation beacon and method of rapid sequence detection and discrimination |
| 05/13/2004 | US20040091859 Vaccinia topoisomerases I-based assays for detection of specific DNA breaks |
| 05/13/2004 | US20040091858 For use in hybridization/purification/immunoassays/biosensors; solid phase synthesis |
| 05/13/2004 | US20040091856 DNA sequences from staphylococcus aureus bacteriophage 44AHJD that encode anti-microbial polypeptides |
| 05/13/2004 | US20040091855 For producing drugs by detecting in vitro complex formations |
| 05/13/2004 | US20040091852 Glycoprotein peptide of the human herpesvirus-7 for use in particular in an elisa serologic test |
| 05/13/2004 | US20040091850 Comprises microfluidic system having releasable molecular tags; electrophoretic separation |
| 05/13/2004 | US20040091635 Remote identification of explosives and other harmful materials |
| 05/13/2004 | US20040091602 Reacting biologically active molecule with masking compound; forming supporting material by controllably introducing on substrate material linker; controlling rate of immobilization reaction; immobilizing masked biologically active molecule |
| 05/13/2004 | US20040091498 Defensins: use as antiviral agents |
| 05/13/2004 | US20040091497 Use as a biological target for the treatment and diagnosis of schizophrenia and bipolar disorder for example; drug screening; transgenic non-human animals for use as animal models |
| 05/13/2004 | US20040091493 Active ingredient such as specified plant extract(s) or calcium compound that does not cause any inflammatory, irritation or intolerance reactions; tissue models for drug screening for drugs against skin disorders; dandruff, acne |
| 05/13/2004 | US20040091481 Method for modulating the binding activity of a novel icam-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes |
| 05/13/2004 | US20040091479 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy |
| 05/13/2004 | US20040091477 Immunophilin-binding compound and ginkgolide compound |
| 05/13/2004 | US20040091476 Enhance or suppress T-cell activation and proliferation |
| 05/13/2004 | US20040091453 Pancreatic langerhans beta cell proliferation promoter and apoptosis inhibitor, and screening of candidate compounds for the e drugs |
| 05/13/2004 | US20040091423 Methods for identifying asymptomatic patients who have a likelihood of benefiting from administration of an estrogen activity modulator for risk reduction or therapeutic treatment of breast cancer, methods for reducing risk or |
| 05/13/2004 | US20040091394 Waveguide optical format enables consistent optical analysis of small sample volumes with minimal variation in light path length among optical formats. The optical format is comprised of an input guide, an output guide, and a sample for guides |
| 05/13/2004 | US20040090614 Spectral analysis of light scattered from clotting blood |
| 05/13/2004 | US20040090345 Scheduled transmission in a wireless sensor system |
| 05/13/2004 | US20040090329 RF based positioning and intrusion detection using a wireless sensor network |
| 05/13/2004 | US20040089847 Dye, solvent; and 2-butoxy ethylacetate, 2-phenylethanol, benzyl alcohol, 4-methoxyphenol and/or cyclohexanol; bacteria |
| 05/13/2004 | US20040089809 Methods of differentiating metastatic and non-metastatic tumors |
| 05/13/2004 | US20040089800 Mass spectrometric analysis of complex mixtures of immune system modulators |
| 05/13/2004 | US20040089535 Low pressure, optics; prevention of target poisoning |
| 05/13/2004 | US20040089079 Semipermeable membrane-based sampling systems |
| 05/13/2004 | DE4321737B4 Gerät zur Detektierung und Messung von oxidierbaren Gasen Device for the detection and measurement of oxidizable gases |
| 05/13/2004 | DE10349914A1 System for the analysis of human or animal body fluids uses test disks, taken from a container by a handle, to be carried through the sample delivery point to the analysis stage |
| 05/13/2004 | DE10349689A1 Adhesive structure monitoring unit, comprises a partially transparent electrode with connections to an impedance spectrometer |
| 05/13/2004 | DE10260216B3 Textile material expansion testing unit, comprises a carrier construction for a fixed holding unit, a movable unit, a stop member and tensioning region clamping jaws |
| 05/13/2004 | DE10256415B3 Transporting charged molecules in aqueous solution, useful in biosensors for DNA analysis, uses a sacrificial electrode to generate metal ions |
| 05/13/2004 | DE10251132A1 Biochip is formed from a continuous solid carrier, fitted with an array of electrodes, a unique identification zone and a transceiver system for chemical and biochemical tests/reactions |
| 05/13/2004 | DE10250530A1 Verfahren zum Nachweis von hepatozellulärem Karzinom und Testsystem Method for detecting hepatocellular carcinoma and Test System |
| 05/13/2004 | DE10250491A1 Determining pyrophosphate, useful e.g. for optimizing polymerase chain reaction conditions or nucleic acid synthesis, uses polymerase with pyrophosphorolysis activity and oligonucleotide as indicator |
| 05/13/2004 | DE10250205A1 Motor vehicle engine oil quality determination method based on a determination of its viscosity from dynamic measurements of the oil level and one or more vehicle kinematic measurements |
| 05/13/2004 | DE10249860A1 Use of neuroglobin for producing a medicament for treating diseases of retina, or for producing a diagnostic agent for diagnosing diseases of the retina |
| 05/13/2004 | DE10247876A1 Verfahren zur Bestimmung von Multimeren von Plasmaproteinen A method for the determination of multimers of plasma proteins |
| 05/13/2004 | DE10233902A1 Messgerät mit einem Griffteil Measuring device with a handle portion |
| 05/13/2004 | DE10105339B4 Verfahren zur fälschungssicheren Markierung, fälschungssichere Markierung und Kit Method for tamperproof label, tamper-proof marking and Kit |
| 05/13/2004 | CA2504512A1 Molecules and methods using same for measuring non-transferrin bound iron |
| 05/13/2004 | CA2504443A1 Methods for producing polypeptide-tagged collections and capture systems containing the tagged polypeptides |
| 05/13/2004 | CA2504323A1 Secretion-testing article |
| 05/13/2004 | CA2504208A1 Multicomponent protein microarrays |
| 05/13/2004 | CA2504178A1 Methods and kits for diagnosing tumorigenicity |
| 05/13/2004 | CA2503711A1 A method and a device for making images of the quantum efficiency of the photosynthetic system with the purpose of determining the quality of plant material and a method and a device for measuring, classifying and sorting plant material |
| 05/13/2004 | CA2503697A1 Trimeric binding proteins for trimeric cytokines |
| 05/13/2004 | CA2503693A1 Use of cpg oligonucleotides in the treatment of hepatitis c virus infection |
| 05/13/2004 | CA2503422A1 Compositions for cancer treatment |
| 05/13/2004 | CA2502849A1 Screening, quantitation and identification of active ingredients in natural products |
| 05/13/2004 | CA2502839A1 Method of using animal models to predict adverse drug reactions |
| 05/13/2004 | CA2502725A1 A method of establishing stress relieving procedures for minimizing sulfide stress cracking in cold worked metals |
| 05/13/2004 | CA2502198A1 Diagnostic method for transmissible spongiform encephalopathies (prion diseases) |
| 05/13/2004 | CA2502088A1 Use of antibodies to the gamma 2 chain of lallminin 5 to inhibit tumor growth and metastasis |
| 05/13/2004 | CA2501180A1 Actriib fusion polypeptides and uses therefor |
| 05/13/2004 | CA2500866A1 Method of measuring binding site on plasma protein of plasma protein-binding drug and method of measuring plasma protein mutation |
| 05/13/2004 | CA2500863A1 Gene reporter assay, kit, and cells for determining the presence and/or the level of a molecule that activates signal transduction activity of a cell surface protein |
| 05/13/2004 | CA2484218A1 Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups |
| 05/13/2004 | CA2473976A1 Ink composition and method for use thereof in the manufacturing of electrochemical sensors |
| 05/12/2004 | EP1418435A1 Method for the preparation of a tissue-factor based reagent for the determination of the prothrombin time |
| 05/12/2004 | EP1418434A2 Non-invasive enzyme screen for tissue remodelling-associated conditions |
| 05/12/2004 | EP1418433A1 Method for detecting hepatocellular carcinoma and testsystem therefor |
| 05/12/2004 | EP1418432A1 Method, assay, and kit for quantifying hiv protease inhibitors |
| 05/12/2004 | EP1418431A1 Nuclear pore protein Nup88 as a novel target |
| 05/12/2004 | EP1418430A2 A homogeneous assay for determining analyte |
| 05/12/2004 | EP1418429A1 METHOD OF QUANTIFYING DENATURED LIPOPROTEIN, REAGENTS FOR QUANTIFYING DENATURED LIPOPROTEIN, METHOD OF DETECTING CIRCULATORY DISEASE AND REAGENTS FOR DETECTING CIRCULATORY DISEASE |
| 05/12/2004 | EP1418428A1 Method to provide natural therapeutic agents with high therapeutic index |
| 05/12/2004 | EP1418427A1 Apparatus and method for measuring electrical processes in biological membranes |
| 05/12/2004 | EP1418422A1 Mass spectrometer |
| 05/12/2004 | EP1418416A1 Process and apparatus for weatherability testing of ink-jet images |
| 05/12/2004 | EP1418368A1 Encoder-equipped sealing device |
| 05/12/2004 | EP1418243A2 Microfluidic system for analyzing nucleic acids |
| 05/12/2004 | EP1418240A1 A method and kit for analyzing a target nucleic acid fragment |
| 05/12/2004 | EP1418239A2 Fluorescence polarization assays involving polyions |
| 05/12/2004 | EP1418238A1 Microbe examining device and method |
| 05/12/2004 | EP1418235A2 Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies |
| 05/12/2004 | EP1418183A1 Cystic fibrosis gene |
| 05/12/2004 | EP1417929A2 Test sensor with thin lancet |
| 05/12/2004 | EP1417862A2 Waterless vessel heating system and method |
| 05/12/2004 | EP1417632A1 Robust stain detection and quantification for histological specimens based on a physical model for stain absorption |